Skip to main content

Disruptive Behavior clinical trials at UC Health

1 in progress, 0 open to eligible people

Showing trials for
  • Prazosin for Agitation in Alzheimer's Disease

    Sorry, in progress, not accepting new patients

    The study evaluates the effects of Prazosin on agitation in adults with Alzheimer's disease. Two thirds of the participants will participate in the medication portion, while one third will participate in the placebo portion

    at UCLA UCSD

Last updated: